Keywords: amylin, narrows, 1st-qtr, loss, 47m, usa, pharmaceuticals
Amylin narrows 1st-qtr loss 34% to $47M
Article | 20 April 2009
The USA's Amylin Pharmaceuticals narrowed its loss in the first quarter of 2009 by 33.8% year-on-year to $47.0 million, or $0.34 per share, thanks ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- New study shows UCB's Neupro reduces NSBP in RLS patient
